Twitter Facebook LinkedIn YouTube

New Listing: Better Life Pharma Inc. (CSE:BETR)

Video Platform Video Management Video Solutions Video Player

BetterLife Pharma Inc. is a science-based innovative medical wellness company aspiring to offer high-quality preventive and self-care products to its customers.

Additional Information:

Company: Better Life Pharma Inc.
Website: http://www.aBetterLifePharma.com
Stock Symbol: CSE: BETR
Date Published: Dec 12, 2019
Transcript: Available

Video Transcript:

I’m Nadika Viswakula for Investmentpitch Media

Better Life Pharma Inc. is one of the latest new listings on the Canadian Securities Exchange, trading under the symbol “BETR”, having previously traded as Pivot Pharmaceuticals.

BetterLife Pharma Inc. is a science-based innovative medical wellness company aspiring to offer high-quality preventive and self-care products to its customers.

BetterLife has developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies that are unique, patent protected and with clear superior benefits to the user such as high absorption, low bioburden and ease of use.

The company is uniquely positioned to execute on its brand leader strategy in its main markets in Germany, US and Canada.

Dr. Toni Rinow, CEO, stated: "2020 marks an important point in our evolution and this new branding reflects our commitment to commercialize science-based innovative medical formulations and to offer high quality preventive and self-care solutions to our customers. We are leveraging our expanding drug delivery IP portfolio and customized formulation capabilities to develop products in compliance with the highest quality standards, respecting tight specifications from raw material to final product and rigorously adhering to best practices."

BetterLife recognizes the importance of creating a market leading brand and is actively working with Joseph Mimran & Associates to brand and market BetterLife's world class phytocannabanoid and nutraceutical products with an immediate focus on BetterLife's product roll out in the US in Q1 2020.


The shares are trading at $0.15.

For more information, please visit the company’s website www.aBetterLifePharma.com, contact Dr. Toni Rinow, CEO, at 438-884-8841 or by email at toni.rinow@bLifePharma.com.

I’m Nadika Viswakula for Investmentpitch Media